Skip to search formSkip to main contentSkip to account menu

Increased Bone Turnover in Prepubertal, Pubertal, and Postpubertal Patients Receiving Carbamazepine

Summary:  Purpose: To study the markers of bone turnover in epilepsy patients in the different stages of the pubertal growth before and after the beginning of carbamazepine (CBZ) monotherapy.
View on Wiley (opens in a new tab)

Metabolic and endocrine effects of valproic acid chronic treatment

View on Elsevier (opens in a new tab)

Increased bone turnover in epileptic patients treated with carbamazepine

It is demonstrated that carbamazepine induces an increase of bone turnover and higher values of markers of bone formation and of bone resorption are found in patients than in controls.
View on Wiley (opens in a new tab)

Autonomic Neuropathy in Diabetes Mellitus

The present review summarizes the latest knowledge regarding clinical presentation, epidemiology, pathogenesis, and management of DAN, with some mention to childhood and adolescent population.
View on PubMed (opens in a new tab)

Panayiotopoulos syndrome: a consensus view

It is concluded that PS is a common idiopathic, benign seizure disorder of childhood, which should be classified as an autonomic epilepsy, rather than an occipital epilepsy.
View on Wiley (opens in a new tab)

Hyperhomocysteinemia in children treated with sodium valproate and carbamazepine

View on Elsevier (opens in a new tab)

Benign convulsions associated with mild gastroenteritis: A multicenter clinical study

View on Elsevier (opens in a new tab)

Typical and atypical rolandic epilepsy in childhood: a follow-up study.

View on PubMed (opens in a new tab)

Weight gain following treatment with valproic acid: pathogenetic mechanisms and clinical implications

Investigation of the possible causal link between treatment and weight gain in epileptic patients to investigate the real extent of this side effect of valproic acid and its clinical implications, such as an increased risk of insulin resistance and other secondary metabolic abnormalities.
View on Wiley (opens in a new tab)

Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): An open-label, parallel group trial

View on Elsevier (opens in a new tab)
...
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)